First Time Loading...

OptiNose Inc
NASDAQ:OPTN

Watchlist Manager
OptiNose Inc Logo
OptiNose Inc
NASDAQ:OPTN
Watchlist
Price: 1.01 USD 15.09% Market Closed
Updated: May 5, 2024

OptiNose Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

OptiNose Inc
Revenue Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
OptiNose Inc
NASDAQ:OPTN
Revenue
$71m
CAGR 3-Years
13%
CAGR 5-Years
59%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Revenue
$85.6B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Revenue
$45.5B
CAGR 3-Years
2%
CAGR 5-Years
14%
CAGR 10-Years
11%
Pfizer Inc
NYSE:PFE
Revenue
$55.1B
CAGR 3-Years
6%
CAGR 5-Years
8%
CAGR 10-Years
1%
Merck & Co Inc
NYSE:MRK
Revenue
$61.4B
CAGR 3-Years
14%
CAGR 5-Years
7%
CAGR 10-Years
3%
Eli Lilly and Co
NYSE:LLY
Revenue
$35.9B
CAGR 3-Years
12%
CAGR 5-Years
11%
CAGR 10-Years
5%

OptiNose Inc
Revenue Breakdown

Breakdown by Geography
OptiNose Inc

Not Available

Breakdown by Segments
OptiNose Inc

Total Revenue: 71m USD
100%
Net Product Revenues: 71m USD
100%

See Also

What is OptiNose Inc's Revenue?
Revenue
71m USD

Based on the financial report for Dec 31, 2023, OptiNose Inc's Revenue amounts to 71m USD.

What is OptiNose Inc's Revenue growth rate?
Revenue CAGR 5Y
59%

Over the last year, the Revenue growth was -7%. The average annual Revenue growth rates for OptiNose Inc have been 13% over the past three years , 59% over the past five years .